- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Fischer hurt by drop in OEM shipments
A sharp drop in product shipments to OEMs in the fourth quarterstung x-ray vendor Fischer Imaging, which reported disappointingyear-end and fourth-quarter financial results last week. The Denvercompany said that a decline in shipments of its Tilt-C C-arm
A sharp drop in product shipments to OEMs in the fourth quarterstung x-ray vendor Fischer Imaging, which reported disappointingyear-end and fourth-quarter financial results last week. The Denvercompany said that a decline in shipments of its Tilt-C C-arm toGE Medical Systems contributed to a 50% drop in OEM sales forthe fourth quarter.
For the year (end-December), Fischer posted revenues of $77.5million, up slightly from revenues of $76.8 million in 1995. Thecompany had a net loss for the year of $361,000, compared withnet income of $2.3 million in 1995.
Fischer's slide was even worse in the fourth quarter, when thecompany recorded revenues of $14.6 million, down 36% comparedwith sales of $23 million in the same period the year before.The vendor's net loss for the most recent quarter was $2.6 million,compared with net income of $1.5 million in the fourth quarterof 1995.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
